{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:59:19Z","timestamp":1767905959804,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00115-017-0441-9","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T06:08:44Z","timestamp":1509084524000},"page":"193-197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neues zur symptomatischen MS-Therapie: Teil\u00a04 \u2013 St\u00f6rungen der Sexualfunktion und der Augenbewegungen","New aspects of symptomatic MS treatment: Part\u00a04\u2014sexual dysfunction and eye movement disorders"],"prefix":"10.1007","volume":"89","author":[{"given":"T.","family":"Henze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Feneberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Flachenecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Starck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"441_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/135245850100700612","volume":"7","author":"FW Foley","year":"2001","unstructured":"Foley FW, LaRocca NG, Sanders AS et\u00a0al (2001) Rehabilitation of intimacy and sexual dysfunction in couples with multiple sclerosis. Mult Scler 7:417\u2013421","journal-title":"Mult Scler"},{"issue":"13","key":"441_CR2","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1177\/1352458514531520","volume":"20","author":"AC L\u00facio","year":"2014","unstructured":"L\u00facio AC, D\u2019Ancona CA, Lopes MH et\u00a0al (2014) The effect of pelvic floor muscle training alone or in combination with electrostimulation in the treatment of sexual dysfunction in women with multiple sclerosis. Mult Scler 20(13):1761\u20131768","journal-title":"Mult Scler"},{"issue":"6","key":"441_CR3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1586\/14737175.6.6.931","volume":"6","author":"AM Landtblom","year":"2006","unstructured":"Landtblom AM (2006) Treatment of erectile dysfunction in multiple sclerosis. Expert Rev Neurother 6(6):931\u2013935","journal-title":"Expert Rev Neurother"},{"key":"441_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009427.pub2","author":"Y Xiao","year":"2012","unstructured":"Xiao Y, Wang J, Luo H (2012) Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis (Review). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD009427.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"441_CR5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.juro.2008.09.003","volume":"181","author":"MR Safarinejad","year":"2009","unstructured":"Safarinejad MR (2009) Evaluation of the safety and efficacy of sildenafil citrate for erectile dysfunction in men with multiple sclerosis: a\u00a0double-blind, placebo controlled, randomized study. J\u00a0Urol 181(1):252\u2013258","journal-title":"J Urol"},{"issue":"3","key":"441_CR6","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/01.ju.0000113145.43174.24","volume":"171","author":"R Dasgupta","year":"2004","unstructured":"Dasgupta R, Wiseman OJ, Kanabar G et\u00a0al (2004) Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis. J\u00a0Urol 171(3):1189\u20131193","journal-title":"J Urol"},{"issue":"2","key":"441_CR7","first-page":"77","volume":"60","author":"G Dachille","year":"2008","unstructured":"Dachille G, Ludovico GM, Pagliarulo G et\u00a0al (2008) Sexual dysfunctions in multiple sclerosis. Minerva Urol Nefrol 60(2):77\u201379","journal-title":"Minerva Urol Nefrol"},{"issue":"6","key":"441_CR8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1743-6109.2010.01797.x","volume":"7","author":"G Lombardi","year":"2010","unstructured":"Lombardi G, Macchiarella A, Del Popolo G (2010) Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J\u00a0Sex Med 7(6):2192\u20132200","journal-title":"J Sex Med"},{"key":"441_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/cmt.4.1.28.41","volume":"4","author":"E Laan","year":"2001","unstructured":"Laan E, van Lunsen RH, Everaerd W (2001) The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 4:28\u201341","journal-title":"Climacteric"},{"key":"441_CR10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00042192-200205000-00004","volume":"9","author":"SR Davis","year":"2002","unstructured":"Davis SR (2002) The effects of tibolone on mood and libido. Menopause 9:162\u2013170","journal-title":"Menopause"},{"key":"441_CR11","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/jnnp.2004.038695","volume":"76","author":"CJ Fowler","year":"2005","unstructured":"Fowler CJ, Miller JR, Sharief MK et\u00a0al (2005) A double blind, randomised study of sildenafil citrate for erectile dysfunction in men with multiple sclerosis. J\u00a0Neurol Neurosurg Psychiatry 76:700\u2013705","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"441_CR12","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/S0022-5347(17)35293-X","volume":"151","author":"MF Godschalk","year":"1994","unstructured":"Godschalk MF, Chen J, Katz PG et al (1994) Treatment of erectile failure with prostaglandin E1: a\u00a0double-blind, placebo-controlled, dose-response study. J\u00a0Urol 151:1530\u20131532","journal-title":"J Urol"},{"key":"441_CR13","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM199604043341401","volume":"334","author":"OI Linet","year":"1996","unstructured":"Linet OI, Ogrinc FG, The Alprostadil Study Group (1996) Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N\u00a0Engl J Med 334:873\u2013877","journal-title":"N Engl J Med"},{"key":"441_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","volume":"336","author":"H Padma-Nathan","year":"1997","unstructured":"Padma-Nathan H, Hellstrom WJ, Kaiser FE et al (1997) Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MU-SE) Study Group. N\u00a0Engl J Med 336:1\u20137","journal-title":"N Engl J Med"},{"issue":"3","key":"441_CR15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00415-009-5309-x","volume":"257","author":"M Starck","year":"2010","unstructured":"Starck M, Albrecht H, P\u00f6llmann W et al (2010) Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. J\u00a0Neurol 257(3):322\u2013327","journal-title":"J Neurol"},{"key":"441_CR16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.21991","volume":"67","author":"M Thurtell","year":"2010","unstructured":"Thurtell M, Joshi AC, Leone AC et\u00a0al (2010) Crossover trial of gabapentin and memantine as treatment for acquired nystagmus. Ann Neurol 67:676\u2013680","journal-title":"Ann Neurol"},{"key":"441_CR17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp.54.7.627","volume":"54","author":"M Dieterich","year":"1991","unstructured":"Dieterich M, Straube A, Brandt T et\u00a0al (1991) The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J\u00a0Neurol Neurosurg Psychiatry 54:627\u2013632","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"441_CR18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","volume":"61","author":"M Strupp","year":"2003","unstructured":"Strupp M, Sch\u00fcler O, Krafcyk S et al (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine. Neurology 61:165\u2013170","journal-title":"Neurology"},{"key":"441_CR19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9394(88)90590-9","volume":"106","author":"EM Helveston","year":"1988","unstructured":"Helveston EM, Pogrebniak AE (1988) Treatment of acquired nystagmus with botulinum A toxin. Am J Ophthalmol 106:584\u2013586","journal-title":"Am J Ophthalmol"},{"key":"441_CR20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ana.410320506","volume":"32","author":"RJ Leigh","year":"1992","unstructured":"Leigh RJ, Tomsak RL, Grant MP et\u00a0al (1992) Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 32:633\u2013642","journal-title":"Ann Neurol"},{"key":"441_CR21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.eye.6700167","volume":"16","author":"GJ Menon","year":"2002","unstructured":"Menon GJ, Thaller VT (2002) Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin \u2014 an effective treatment for acquired nystagmus with oscillopsia. Eye (Lond) 16:804\u2013806","journal-title":"Eye (Lond)"},{"key":"441_CR22","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1212\/WNL.53.9.2209-a","volume":"53","author":"F Schon","year":"1999","unstructured":"Schon F, Hart PE, Hodgson TL et\u00a0al (1999) Suppression of pendular nystagmus by smoking cannabis in a\u00a0patient with multiple sclerosis. Neurology 53:2209\u20132210","journal-title":"Neurology"},{"key":"441_CR23","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/WNL.56.11.1514","volume":"56","author":"JH Noseworthy","year":"2001","unstructured":"Noseworthy JH, O\u2019Brien PC, Petterson TM et\u00a0al (2001) A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis. Neurology 56:1514\u20131522","journal-title":"Neurology"},{"key":"441_CR24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","volume":"15","author":"A Tselis","year":"2008","unstructured":"Tselis A, Perumal J, Caon C et\u00a0al (2008) Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin. Eur J Neurol 15:1163\u20131167","journal-title":"Eur J Neurol"},{"issue":"138","key":"441_CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/brain\/awu335","volume":"1","author":"LJ Balcer","year":"2015","unstructured":"Balcer LJ, Miller DH, Reingold SC et al (2015) Vision and vision-related outcome measures in multiple sclerosis. Brain 1(138):11\u201327","journal-title":"Brain"},{"issue":"3","key":"441_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(16)00004-1","volume":"15","author":"R Raftopoulos","year":"2016","unstructured":"Raftopoulos R, Hickman SJ, Toosy A et al (2016) Phenytoin for neuroprotection in patients with acute optic neuritis: a\u00a0randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15(3):259\u2013269","journal-title":"Lancet Neurol"},{"issue":"3","key":"441_CR27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/WCO.0000000000000327","volume":"29","author":"O Aktas","year":"2016","unstructured":"Aktas O, Albrecht P, Hartung HP (2016) Optic neuritis as a\u00a0phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. Curr Opin Neurol 29(3):199\u2013204","journal-title":"Curr Opin Neurol"},{"key":"441_CR28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjo.2005.086322","volume":"90","author":"T Shery","year":"2006","unstructured":"Shery T, Proudlock FA, Sarvananthan N et\u00a0al (2006) The effects of gabapentin and memantine in acquired and congenital nystagmus \u2014 a retrospective study. Br J Ophthalmol 90:839\u2013843","journal-title":"Br J Ophthalmol"},{"key":"441_CR29","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ana.410410620","volume":"41","author":"L Averbuch-Heller","year":"1997","unstructured":"Averbuch-Heller L, Tusa RJ, Fuhry L et al (1997) A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 41:818\u2013825","journal-title":"Ann Neurol"},{"key":"441_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007728","volume":"244","author":"M Starck","year":"1997","unstructured":"Starck M, Albrecht H, P\u00f6llmann W et\u00a0al (1997) Drug therapy for acquired pendular nystagmus in multiple sclerosis. J\u00a0Neurol 244:9\u201316","journal-title":"J Neurol"},{"key":"441_CR31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.71.1.107","volume":"71","author":"F Bandini","year":"2001","unstructured":"Bandini F, Castello E, Mazzella L et\u00a0al (2001) Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: how valid is the GABAergic hypothesis? J\u00a0Neurol Neurosurg Psychiatry 71:107\u2013110","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0441-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0441-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0441-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T02:32:50Z","timestamp":1719541970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0441-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["441"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0441-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]}}}